Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
---|---|---|---|---|---|---|---|---|---|
OCX | Oncocyte Corp | Common Stock, no par value | 40.2% | $44.7M | 11.6M | NEAL C. BRADSHER | Feb 6, 2025 | ||
STAA | STAAR SURGICAL CO | Common Stock, par value $0.01 per share | 27.1% | $233M | 13.4M | BRADSHER, NEAL C. | Apr 4, 2025 | ||
LCTX | Lineage Cell Therapeutics, Inc. | Common Shares, no par value | 24.5% | $30.1M | 57.8M | NEAL C. BRADSHER | Jan 27, 2025 |
Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
---|